99 related articles for article (PubMed ID: 3080019)
1. Immunological phenotype of neoplasms involving the B cell in the last step of differentiation.
San Miguel JF; Caballero MD; Gonzalez M; Zola H; Lopez Borrasca A
Br J Haematol; 1986 Jan; 62(1):75-83. PubMed ID: 3080019
[TBL] [Abstract][Full Text] [Related]
2. Multiple myeloma: circulating lymphocytes that express plasma cell antigens.
Ruiz-Argüelles GJ; Katzmann JA; Greipp PR; Gonchoroff NJ; Garton JP; Kyle RA
Blood; 1984 Aug; 64(2):352-6. PubMed ID: 6611178
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
4. Two monoclonal antibodies (OKIa1 and OKT10) for the study of the final B cell maturation.
Van Camp B; Thielemans C; Dehou MF; De Mey J; De Waele M
J Clin Immunol; 1982 Jul; 2(3 Suppl):67S-74S. PubMed ID: 6813349
[TBL] [Abstract][Full Text] [Related]
5. Surface expression of human myeloma cells: an analysis using a panel of monoclonal antibodies.
Katagiri S; Yonezawa T; Tamaki T; Kanayama Y; Kuyama J; Ohnishi M; Tsubakio T; Kurata Y; Tarui S
Acta Haematol; 1984; 72(6):372-8. PubMed ID: 6442520
[TBL] [Abstract][Full Text] [Related]
6. Multiparameter analyses of normal and malignant human plasma cells: CD38++, CD56+, CD54+, cIg+ is the common phenotype of myeloma cells.
Leo R; Boeker M; Peest D; Hein R; Bartl R; Gessner JE; Selbach J; Wacker G; Deicher H
Ann Hematol; 1992 Mar; 64(3):132-9. PubMed ID: 1373957
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic analysis of Waldenstrom's macroglobulinemia.
San Miguel JF; Vidriales MB; Ocio E; Mateo G; Sánchez-Guijo F; Sánchez ML; Escribano L; Bárez A; Moro MJ; Hernández J; Aguilera C; Cuello R; García-Frade J; López R; Portero J; Orfao A
Semin Oncol; 2003 Apr; 30(2):187-95. PubMed ID: 12720134
[TBL] [Abstract][Full Text] [Related]
8. Analysis of leucocyte differentiation antigens in blood and bone marrow from patients with Waldenström's macroglobulinaemia.
Kucharska-Pulczynska M; Ellegaard J; Hokland P
Br J Haematol; 1987 Apr; 65(4):395-9. PubMed ID: 3107610
[TBL] [Abstract][Full Text] [Related]
9. Treatment of plasma cell dyscrasias by antibody-mediated immunotherapy.
Treon SP; Shima Y; Preffer FI; Doss DS; Ellman L; Schlossman RL; Grossbard ML; Belch AR; Pilarski LM; Anderson KC
Semin Oncol; 1999 Oct; 26(5 Suppl 14):97-106. PubMed ID: 10561024
[TBL] [Abstract][Full Text] [Related]
10. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotypic analysis of lymphocytes and myeloma cells in patients with multiple myeloma.
Shimazaki C; Fried J; Perez AG; Scheinberg DA; Atzpodien J; Wang CY; Wisniewolski R; Clarkson BD
Acta Haematol; 1990; 83(3):123-9. PubMed ID: 2109450
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a monoclonal antibody having selective reactivity with normal and neoplastic plasma cells.
Tong AW; Lee JC; Stone MJ
Blood; 1987 Jan; 69(1):238-45. PubMed ID: 3098320
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals.
Gutiérrez NC; Ocio EM; de Las Rivas J; Maiso P; Delgado M; Fermiñán E; Arcos MJ; Sánchez ML; Hernández JM; San Miguel JF
Leukemia; 2007 Mar; 21(3):541-9. PubMed ID: 17252022
[TBL] [Abstract][Full Text] [Related]
14. Mitogenic stimulation of malignant B cells Waldenstrøm's macroglobulinaemia: secretion of monoclonal IgM by in vitro-induced plasmablasts.
Bloem AC; Chand MA; van Camp B; Bast EJ; Ballieux RE
Clin Exp Immunol; 1986 Jan; 63(1):156-62. PubMed ID: 3082547
[TBL] [Abstract][Full Text] [Related]
15. Role of plasma cells in Waldenström macroglobulinaemia.
El-Ayoubi A; Wang JQ; Hein N; Talaulikar D
Pathology; 2017 Jun; 49(4):337-345. PubMed ID: 28483372
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical detection of kappa and lambda light chain V region subgroups in human B-cell malignancies.
Solomon A; Weiss DT; Macy SD; Antonucci RA
Am J Pathol; 1990 Oct; 137(4):855-62. PubMed ID: 2121042
[TBL] [Abstract][Full Text] [Related]
17. Studies on the origin of the precursor cells in multiple myeloma, Waldenström's macroglobulinaemia and benign monoclonal gammopathy. I. Cytoplasmic isotype and idiotype distribution in peripheral blood and bone marrow.
Van Camp B; Reynaert P; Broodtaerts L
Clin Exp Immunol; 1981 Apr; 44(1):82-9. PubMed ID: 6790210
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the monoclonal blood and bone marrow B lymphocytes in Waldenström's macroglobulinaemia.
Pettersson D; Mellstedt H; Holm G
Scand J Immunol; 1980; 11(6):593-9. PubMed ID: 6777864
[TBL] [Abstract][Full Text] [Related]
19. A novel membrane antigen selectively expressed on terminally differentiated human B cells.
Goto T; Kennel SJ; Abe M; Takishita M; Kosaka M; Solomon A; Saito S
Blood; 1994 Sep; 84(6):1922-30. PubMed ID: 8080996
[TBL] [Abstract][Full Text] [Related]
20. Origin of Waldenstrom's macroglobulinaemia.
García-Sanz R; Jiménez C; Puig N; Paiva B; Gutiérrez NC; Rodríguez-Otero P; Almeida J; San Miguel J; Orfão A; González M; Pérez-Andrés M
Best Pract Res Clin Haematol; 2016 Jun; 29(2):136-147. PubMed ID: 27825459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
